Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
about
Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.Ipilimumab augments antitumor activity of bispecific antibody-armed T cellsSoluble IL-2Rα (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in miceToll-like receptor 4 engagement drives differentiation of human and murine dendritic cells from a pro- into an anti-inflammatory mode.Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphomaSoluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomasPretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyAggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patientsChinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study.Altered serum cytokine signature in common variable immunodeficiencyA pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.Memory T Cells in Type 1 Diabetes: the Devil is in the Detail.Host factors associated with serologic inflammatory markers assessed using multiplex assays.Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin.Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study.Manipulating IL-2 and IL-2R in autoimmune diseases and transplantation.High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guérin.Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era.Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients.A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.
P2860
Q33777159-ACB57C8F-B65E-456A-98FE-EE9012887C41Q33929184-A8A819A7-8CE9-4AA3-998E-E28AB01E2616Q34451078-E6ADDCE7-F082-473A-8DA9-72F9A8F9A32EQ34585902-79176F43-13EE-4683-9F5D-2BB7514DCB8DQ34626318-455681A0-D08A-4287-8F8F-902C9CA92A8AQ34649178-4D58613D-298D-4FDF-A45A-D007DB093E28Q35056309-4C92C42B-3E05-42BF-A063-2BFDE2AD16DDQ35203067-D45A003C-7602-42EF-97B2-4DE5882B3A1BQ35777301-C28E53E6-EF75-4533-979C-4DE9935CA0A7Q36191426-6606C0C6-F94C-4AF4-BE79-B4812D2D4E1CQ36201411-AF337AAC-71B6-4601-8D30-707A802546AAQ36354265-4DC57444-871B-48B7-9B6C-DC83645BC300Q36476656-6BF5188B-8981-41A2-8BAB-A8AFBAAAED4FQ36869519-0C8E0269-76DD-4365-AB50-93F02352F6E6Q36909039-A11F4C22-8F82-460B-9CD4-A1EB284F3CFFQ36993980-3A436426-EFBC-4EBA-A8AF-A0E02E65DB0AQ37207618-203CDF64-F522-4048-9925-CC82FFFD735EQ37402310-6D611D16-372B-4DBC-9622-19BC2E59F6B2Q37471644-0201CD96-4173-47D1-9349-E7A1A22C7E90Q38208771-1B8F9CA4-C396-42BF-B8F2-467E70B953DDQ38344066-2DB51C5B-FE80-4E19-9E9A-26E02B7C0C35Q38577849-7776ED79-8A2A-43EE-A910-BD6204AA1962Q38705223-7AF3901F-0E69-4A7B-96EA-79D3373E171EQ38850729-A5C73956-3DDD-4AFC-88C0-04B1DFEDA6A9Q39410575-438F0757-36B7-418E-87B0-033004EF7396Q40704505-0AF9D040-5637-4748-BBFF-9E7CE628BA41Q42283552-BEE50484-F113-4936-8326-5A074F0BA4F6Q45398897-E334BE35-5B33-4577-81ED-E4A4ED8E8C36Q46268804-F92F9919-FDA7-4E00-9A5C-0E26811BB05FQ47149317-3BD3D94D-E3EE-41D5-9D36-43751C488A5EQ47156338-91CEFB5F-F0CD-402A-86CB-95689B2E317FQ47232472-EC518EB4-B5A6-4B8C-845F-509382A95677Q47856794-494EDC85-E1B0-457F-91EF-8ECEC076AF20Q51634768-550C8226-7A06-4914-BF84-362003A8F9CAQ52865502-BC09B5B8-85BC-4991-BBF7-641F44F6D3F1Q53090167-6FCFAF91-2007-4338-A3EE-A40F86D3E9A1Q53100526-538C357F-535C-483B-A4AE-17B16AF3635DQ53527300-4CF18D54-3196-4B7E-87C0-4816BF30E904Q55083652-44B852FB-7045-46FC-91EE-33545DFE96CCQ55456412-A2C2EFD3-6AAF-4A8A-8EA6-53562A964D93
P2860
Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@ast
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@en
type
label
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@ast
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@en
prefLabel
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@ast
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@en
P2093
P2860
P1433
P1476
Soluble IL-2Rα facilitates IL- ...... r B-cell non-Hodgkin lymphoma.
@en
P2093
Anne J Novak
Deanna M Grote
Michelle K Manske
Stephen M Ansell
Steven C Ziesmer
Thomas E Witzig
Zhi-Zhang Yang
P2860
P304
P356
10.1182/BLOOD-2011-03-340885
P407
P577
2011-06-30T00:00:00Z